Diabetes Technology & Care Coordination

NURS-FPX 4900 Assessment 3: Diabetes Technology & Care Coordination

Introduction

Managing Type 1 and Type 2 Diabetes has advanced beyond traditional fingerstick monitoring methods. Modern diabetes technology provides continuous real-time data that can significantly reduce HbA1c levels and stop long-term problems when used effectively. This paper looks at how to include Continuous Glucose Monitoring (CGM) in a care coordination framework. It stresses how important it is to use ethical principles when choosing and using these digital tools.

The Role of CGM in Care Coordination

Continuous Glucose Monitoring (CGM) provides real-time glucose readings every 5 to 15 minutes. Unlike traditional testing, CGM reveals the “Time in Range” (TIR), which is a more accurate predictor of vascular health. In a coordinated care model, this data is uploaded to a cloud-based server where the entire interdisciplinary team can view it. This allows for “Proactive Intervention” rather than waiting for a quarterly laboratory visit.

Applying Ethical Principles to Diabetes Technology

Justice and the Digital Divide

Justice is the most important moral issue in diabetes care right now. Insulin pumps and CGMs are examples of high-tech devices that cost a lot of money and often need better insurance coverage. When a nurse uses ethical principles, they are acting as an advocate for social justice. The nurse must challenge the “standard” and look for other ways to get funding or push for policy changes if a patient is turned down for a CGM because of their socioeconomic status. This is to make sure that access to life-saving technology is not limited to individuals with higher socioeconomic status. 

Autonomy and Data Privacy

With the “Internet of Medical Things” (IoMT), patient data is continuously transmitted across digital platforms. Respecting Autonomy means ensuring the patient understands who has access to their glucose data. Applying Ethical Principles involves the nurse must provide clear explanations of the privacy safeguards of the technology and ensure the patient has given informed consent for their data to be shared with the interdisciplinary team.

Beneficence and Non-maleficence

Beneficence is achieved when technology reduces the patient’s “Diabetes Distress” and enhances overall quality of life. However, we must also consider Non-maleficence. “Alarm Fatigue” or the excessive data burden from a CGM can lead to psychological harm or “over-correction” with insulin. An ethical care plan includes education on how to interpret data without causing mental health strain.

Collaborative Strategies for Technology Adoption

Effective care coordination requires a “Shared Mental Model.” The nurse coordinator facilitates “Data Review Huddles” where the CDCES and pharmacist review CGM reports to identify patterns like “Somogyi Effect” or “Dawn Phenomenon.” By utilizing TeamSTEPPS communication strategies, the team ensures that the patient’s technological data is translated into actionable clinical insights.